Table:
No. Case	Diagnosis	Sex	Age	CALR mutation	CALR allele burden (%)	JAK2 allele burden (%)	Reference
1	ET	U	U	U	U	U	[4]
2	RARS-T	F	73	c.1129_1138del	U	4	[5]
3	PMF	U	U	c.1092_1143del (type 1)	U	U	[6]
4	ET	F	79	c.1094_1139del (type 6)	10.5	<1	[7]
5–8	PMF	U	U	U	U	U	[8]
9	ET	U	U	c.1092_1143del (type 1)	U	0.03	[9]
10	ET	F	62	c.1095_1140del (type 3)	24.22	0.16	this study
11	ET	M	29	c.1144del	50.37	0.27	this study
12	ET	F	71	c.1092_1143del (type 1)	61.08	0.12	this study
13	ET	F	61	U*	4.47	0.10	this study
14	ET	F	74	c.1092_1143del (type 1)	89.48	0.38	this study
15	ET	M	37	c.1092_1143del (type 1)	40.65	0.14	this study
16	ET	M	57	c.1154_1155insTTGTC (type 2)	36.92	0.26	this study
17	ET	F	77	c.1092_1143del (type 1)	47.54	0.28	this study

What are the following illustration content in markdown style: | No. Case | Diagnosis | Sex | Age | CALR mutation | CALR allele burden (%) | JAK2 allele burden (%) | Reference | 
 | --- | --- | --- | --- | --- | --- | --- | --- | 
 | 1 | ET | U | U | U | U | U | [4] | 
 | 2 | RARS-T | F | 73 | c.1129_1138del | U | 4 | [5] | 
 | 3 | PMF | U | U | c.1092_1143del (type 1) | U | U | [6] | 
 | 4 | ET | F | 79 | c.1094_1139del (type 6) | 10.5 | <1 | [7] | 
 | 5–8 | PMF | U | U | U | U | U | [8] | 
 | 9 | ET | U | U | c.1092_1143del (type 1) | U | 0.03 | [9] | 
 | 10

| ET | F | 62 | c.1095_1140del (type 3) | 24.22 | 0.16 | this study | 
 | 11 | ET | M | 29 | c.1144del | 50.37 | 0.27 | this study | 
 | 12 | ET | F | 71 | c.1092_1143del (type 1) | 61.08 | 0.12 | this study | 
 | 13 | ET | F | 61 | U* | 4.47 | 0.10 | this study | 
 | 14 | ET | F | 74 | c.1092_1143del (type 1) | 89.48 | 0.38 | this study | 
 | 15 | ET | M | 37 | c.1092_1143del (type 1) | 40.65 | 0.14 | this study | 
 | 16 | ET | M | 57 | c.1154_1155insTTGTC (type 2) | 36.92 | 0.26 | this study | 
 | 17 | ET | F | 77 | c.1092_1143del (type 1) | 47.54 | 0.28 | this study |